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Abstract
Introduction Cachexia and obesity have been suggested
to be risk factors for postoperative complications. How-
ever, high body mass index (BMI) might result in a higher
R0-resection rate because of the presence of more fatty
tissue surrounding the tumor. The purpose of this study was
to investigate whether BMI is of prognostic value with
regard to short-term and long-term outcome in patients
who undergo esophagectomy for cancer.
Methods In 556 patients who underwent esophagectomy
(1991–2007), clinical and pathological outcome were
compared between different BMI classes (underweight,
normal weight, overweight, obesity).
Results Overall morbidity, mortality, and reoperation rate
did not differ in underweight and obese patients. However,
severe complications seemed to occur more often in obese
patients (p = 0.06), and the risk for anastomotic leakage
increased with higher BMI (12.5% in underweight patients
compared with 27.6% in obese patients, p = 0.04). Histo-
pathological assessment showed comparable pTNM stages,
although an advanced pT stage was seen more often in
patients with low/normal BMI (p = 0.02). A linear asso-
ciation between BMI and R0-resection rate was detected
(p = 0.02): 60% in underweight patients compared with
81% in obese patients. However, unlike pT-stage
(p \ 0.001), BMI was not an independent predictor for R0
resection (p = 0.12). There was no significant difference in
overall or disease-free 5-year survival between the BMI
classes (p = 0.25 and p = 0.6, respectively).
Conclusions BMI is not of prognostic value with regard
to short-term and long-term outcome in patients who
undergo esophagectomy for cancer and is not an indepen-
dent predictor for radical R0 resection. Patients oncologi-
cally eligible for esophagectomy should not be denied
surgery on the basis of their BMI class.
Introduction
Among patients with esophageal cancer weight loss is
common, which is caused by malnutrition due to reduced
food intake (mostly related to dysphagia) and increased
demands because of systemic inflammation (cancer
cachexia) [1]. Malnutrition has long been recognized as a
condition associated with an increased risk of postoperative
complications [2], in particular infectious complications [3].
It is unclear which mechanism is responsible for the rela-
tionship between malnutrition and an adverse short-term
clinical outcome, but a combination of immune, inflamma-
tory, and metabolic processes is thought to play a role [3].
The prevalence of obesity (defined as body mass index
(BMI) [ 30.00) among adults has increased over the past
decades in the Western world [4, 5]. Obesity is associated with
several medical comorbidities, including diabetes, hyperten-
sion, and coronary artery disease [6]. In addition, increased
BMI is associated with a higher risk of several types of cancers
[7], including esophageal adenocarcinoma [8]. Surgery and
anesthesia are more hazardous in overweight patients, not
least because of the increased incidence of cardiorespiratory
comorbidity [9]. Obese patients are at a higher risk for
developing respiratory complications, because their pulmon-
ary function is characterized by reductions in functional
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residual capacity and expiratory reserve volume [9–11]. The
presence of excessive subcutaneous fat also may predispose
obese patients to impaired wound healing and wound infec-
tions [12]. On the other hand, it might be hypothesized that in
patients with a high BMI (and increased visceral fatty tissue), a
higher percentage of tumor-free circumferential resection
margins might be achieved because of the presence of more
fatty tissue surrounding the tumor compared with patients
with a low BMI when performing esophagectomy for cancer.
To improve outcome after esophagectomy, an optimal
treatment strategy should be based on appropriate patient
selection, which is strongly influenced by preoperative risk
assessment. However, preoperative nutritional condition
has received minor attention in risk analyses for esopha-
gectomy thus far. The purpose of the present study was to
investigate whether BMI is of prognostic value with regard
to postoperative short-term and long-term outcomes in
patients who undergo esophagectomy for cancer. We
hypothesized on the one hand that patients with under-
weight or obesity are at higher risk for perioperative
morbidity and mortality after esophagectomy, and that on
the other hand increased BMI with excessive peritumoral
fatty tissue might facilitate a radical (R0-) resection.
Patients and methods
Patients
Between January 1991 and December 2007, 791 patients
underwent an esophagectomy for cancer of the esophagus or
gastroesophageal junction in the Erasmus Medical Center in
Rotterdam, The Netherlands. Only patients in whom no
chemo- and/or radiotherapy was applied and who underwent
a transthoracic or transhiatal esophagectomy were included
in the present study. In the Erasmus MC, patients received
neoadjuvant chemo(radio)therapy in the context of clinical
trials [13]. Induction chemo- and/or radiotherapy was given
to patients with a cT4-tumor without distant metastases or to
patients with gross involvement of celiac trunk lymph nodes
(M1a), who were not considered eligible for primary surgical
therapy. There were 214 patients who were excluded because
of chemo- and/or radiotherapy before surgery and 21 patients
because of unknown preoperative BMI. The remaining 556
patients were included in this study.
Surgery
The majority of patients underwent a transhiatal esophagec-
tomy (N = 541). The primary tumor and its adjacent lymph
nodes were dissected under direct vision through the widened
hiatus of the diaphragm up to the level of the inferior pul-
monary vein. In addition, all adjacent fatty tissue surrounding
the tumor was removed simultaneously, until the lateral
resection margins were reached (diaphragm, pleura, pericar-
dium, aorta). Subsequently, a gastric tube was created. The left
gastric artery was transected at its origin, with resection of
celiac trunk lymph nodes. After mobilization and transection
of the cervical esophagus, the normal intrathoracic esophagus
proximal to the primary tumor was mobilized bluntly from the
neck to the abdomen with a vein stripper. Esophagogastros-
tomy (handsewn or by using a circular stapler) was performed
in the neck. Posterolateral thoracotomy was the first step in
transthoracic resection with extended lymphadenectomy
(N = 15). The thoracic duct, azygos vein, ipsilateral pleura,
and all periesophageal tissue in the posterior mediastinum
were dissected en bloc. The resection specimen included the
lower and middle mediastinal, subcarinal, and right-sided
paratracheal lymph nodes. The aorta–pulmonary-window
nodes were dissected separately. Through a midline laparot-
omy, the paracardial, lesser curvature, left-gastric-artery,
celiac trunk, common-hepatic-artery, and splenic-artery nodes
were dissected, and a gastric tube was constructed. The cer-
vical phase of the transthoracic procedure was identical to that
of the transhiatal procedure. Tumors were assigned pathologic
tumor-node-metastasis stages according to the Union Inter-
nationale Contre le Cancer (UICC) 2002 system [14].
Data collection
Patients’ weight and length were measured at their first
visit to the outpatient clinic. Patients’ BMI was calculated
and classified according to the World Health Organization
criteria (underweight: BMI \ 18.50 kg/m2; normal weight:
BMI 18.50–24.99 kg/m2; overweight: BMI 25.00–29.99
kg/m2; obesity: BMI C 30.00 kg/m2) [15]. Outcome data
(including half-yearly follow-up) for all patients with
esophageal cancer referred to our hospital for further
analysis and treatment had been collected prospectively
and stored in a database by a specialized data manager.
Follow-up was recorded until December 2008 or until
death if earlier and was complete for all patients.
Statistics
To address the question of whether patients with underweight
or obesity are at higher risk for perioperative morbidity and
mortality after esophagectomy, short-term outcome of under-
weight and obese patients was compared with outcome of the
control group (patients with normal weight or overweight). The
potential impact of BMI on histopathological outcome was
considered to be on a linear scale (i.e., increased BMI might
result in a higher percentage R0 resections) and was analyzed
by comparing patients’ outcome of the four BMI classes.
Statistical analysis appropriate for nonparametric data
was used. Grouped data as presented in Tables 1 and 2
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Table 1 Impact of underweight
and obesity on postoperative
complications and in-hospital
mortality in patients undergoing
esophagectomy for cancer
compared with the control
group (normal weight and
overweight patients)
BMI body mass index
* Respiratory insufficiency was
defined as pulmonary
dysfunction requiring prolonged
ventilation ([10 days) or
reintubation
Underweight Control group Obesity p value
BMI \ 18.50
(N = 40)
BMI 18.50–29.99
(N = 458)
BMI C 30.00
(N = 58)
Postoperative complications 20 (50%) 294 (64.2%) 34 (58.6%) 0.17
Surgical complications
Bleeding 1 (2.5%) 13 (2.8%) 0 (0%) 0.43
Chyle leakage 1 (2.5%) 12 (12.6%) 1 (1.7%) 0.92
Anastomotic leakage 5 (12.5%) 77 (16.8%) 16 (27.6%) 0.09
Conduit necrosis 0 (0.0%) 11 (2.4%) 1 (1.7%) 0.59
Vocal cord paresis 4 (10.0%) 67 (14.6%) 4 (6.9%) 0.16
Wound infection 1 (2.5%) 43 (9.4%) 7 (12.1%) 0.25
Medical complications
Sepsis 1 (2.5%) 29 (6.3%) 3 (5.2%) 0.6
Pneumonia 11 (27.5%) 149 (32.5%) 12 (20.7%) 0.16
Respiratory insufficiency* 5 (12.5%) 40 (8.7%) 6 (10.3%) 0.69
Atrial fibrillation 3 (7.5%) 39 (8.5%) 3 (5.2%) 0.67
Myocardial infarction 0 (0%) 5 (1.1%) 2 (3.4%) 0.24
Thromboembolism 0 (0%) 10 (2.2%) 2 (3.4%) 0.51
Reoperation 3 (7.5%) 54 (11.8%) 5 (8.6%) 0.58
In-hospital mortality 1 (2.5%) 27 (5.9%) 5 (8.6%) 0.45
Table 2 Histopathological
assessment of the resection
specimens in relation to four
BMI classes in 556 patients who
underwent surgical resection for
esophageal cancer
BMI body mass index,
SCC squamous cell carcinoma,
AC adenocarcinoma, lymph
node ratio number of positive
lymph nodes/total number of
harvested lymph nodes
* Values presented as median
(range in brackets)
Underweight
BMI \ 18.50
N = 40
Normal weight
BMI 18.50–24.99
N = 244
Overweight
BMI 25.00–29.99
N = 214
Obesity
BMI C 30.00
N = 58
p-value
Histology
SCC 22 (55.0%) 29 (11.9%) 26 (12.1%) 6 (10.3%)
AC 18 (45.0%) 215 (88.1%) 188 (87.9%) 52 (89.7%) \0.001
pT-status
T1–T2 10 (25.0%) 65 (26.6%) 83 (38.8%) 23 (39.7%)
T3–T4 30 (75.0%) 179 (73.4%) 131 (61.2%) 35 (60.3%) 0.02
pN-status
N0 16 (40.0%) 84 (34.4%) 81 (37.9%) 24 (41.4%)
N1 24 (60.0%) 160 (65.6%) 133 (62.2%) 34 (58.6%) 0.94
pM-status
M0 32 (80.0%) 194 (79.5%) 164 (76.6%) 47 (81.0%)
M1a–M1b 8 (20.0%) 50 (20.5%) 50 (23.4%) 11 (19.0%) 0.84
Differentiation grade
G1 (good) 4 (10.0%) 14 (5.7%) 17 (7.9%) 4 (6.9%)
G2 (moderate) 26 (65.0%) 111 (45.5%) 95 (44.4%) 22 (37.9%)
G3 (poor) 10 (25.0%) 119 (48.8%) 102 (47.7%) 32 (55.2%) 0.17
Type of resection
R0 24 (60.0%) 167 (68.4%) 154 (72.0%) 47 (81.0%)
R1–R2 16 (40.0%) 77 (31.6%) 60 (28.0%) 11 (19.0%) 0.06
Number of positive
lymph nodes*
1 (1–19) 2 (0–23) 2 (0–43) 1 (0–11) 0.14
Total number
of harvested
lymph nodes*
10 (3–45) 12 (1–56) 10 (1–43) 9 (2–31) 0.10
Lymph node
ratio*
0.10 0.17 0.16 0.10 0.14
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were compared using the Chi-squared, Mann–Whitney U,
or Kruskal–Wallis H test. In case these tests were signifi-
cant (thereby indicating that there were differences but not
indicating where the differences are), groups were com-
pared pair-wise with adding the Bonferroni correction.
Trend-analysis and logistic regression were performed to
reveal linear associations with regard to BMI.
Overall survival was calculated from the date of oper-
ation until the date of last follow-up or death according to
the Kaplan–Meier method. Patients who died due to
complications after esophagectomy (in-hospital mortality)
were not excluded from survival analysis. Univariate
analyses were performed to identify prognostic variables
associated with overall survival after esophagectomy.
Data analysis was performed with SPSS version 15.0
(SPSS, Inc., Chicago, IL, USA). Two-sided p values\0.05
were considered to be significant.
Results
Patients’ characteristics
Patients’ characteristics are described in Table 3. Forty patients
(7.2%) were classified as underweight (BMI\ 18.50 kg/m2),
244 patients (43.9%) had a normal weight (BMI 18.50–
24.99 kg/m2), 214 patients (38.5%) were overweight (BMI
25.00–29.99 kg/m2), whereas obesity (BMI [30.00) was
diagnosed in 58 patients (10.4%).
Short-term outcome
Median operative time for all patients was 280 (range,
120–572) min. Operative time increased among the dif-
ferent BMI classes: median operative time was 266 min in
underweight patients, 274 min in normal weight, 285 min
in overweight, and 307 min in obese patients (p = 0.04).
There was no significant difference in length of ICU-MCU
(median, 4 days) or hospital stay (median, 14 days)
between the different groups. When analyzing the effect of
underweight or obesity on patients’ short-term outcome,
overall morbidity, reoperation rate, and in-hospital mor-
tality were similar to those of the patients in the control
group (normal weight or overweight; Table 1). However,
when the grade of complications was taken into account,
severe complications seemed to occur more often in obese
patients than in the control group (36.4 vs. 21.8%,
p = 0.06). Furthermore, the incidence of anastomotic
leakage (radiological as well as clinical) did not seem
comparable between the three groups (p = 0.09). On trend
analysis, a linear association between BMI and anastomotic
leakage was detected (p = 0.04): the risk for anastomotic
leakage increased with higher BMI (from 12.5% in
underweight patients to 27.6% in obese patients). Also, a
trend for a linear association between BMI and wound
infection was seen (p = 0.07): from 2.5% in underweight
patients to 12.1% in obese patients.
Histopathological assessment for the four different BMI
classes is shown in Table 2. Advanced pT stage was seen
significantly more often in patients with a low or normal
BMI (p \ 0.01). Patients with overweight or obesity
appeared to participate more often in a surveillance pro-
gram than patients with a low or normal BMI (28.8 vs.
17.1%, p = 0.21). Underweight patients mostly suffered
from squamous cell carcinoma (55%), whereas the majority
of patients with normal weight, overweight, or obesity was
diagnosed with adenocarcinoma (89%; p \ 0.001). A trend
toward a higher rate of radical resection (R0) across the
BMI classes was noted (p = 0.06). On trend analysis, a
linear association between BMI and R0-resection rate was
detected (p = 0.02): 60% in underweight patients versus
81% in obese patients. However, unlike pT stage
(p \ 0.001), BMI was not an independent predictor for R0-
resection on logistic regression (p = 0.12). Stratification
for tumor location (esophagus vs. gastroesophageal junc-
tion) did not influence the R0-resection rate.
Table 3 Clinicopathological characteristics of 556 patients who
underwent surgical resection for esophageal cancer
Age (year)* 65 (range 28–89)
Gender
Male 450 (80.9%)
Female 106 (19.1%)
ASA classification
I 82 (14.7%)
II 364 (65.5%)
III 106 (19.1%)
IV 4 (0.7%)
BMI class
Underweight (BMI \ 18.50) 40 (7.2%)
Normal weight (BMI 18.50–24.99) 244 (43.9%)
Overweight (BMI 25.00–29.99) 214 (38.5%)
Obesity (BMI C 30.00) 58 (10.4%)
Tumor location
Proximal esophagus 9 (1.6%)
Mid esophagus 32 (5.8%)
Distal esophagus 232 (41.7%)
Gastroesophageal junction 283 (50.9%)
Histology
Squamous cell carcinoma 83 (14.9%)
Adenocarcinoma 473 (85.1%)
ASA classification American society of anesthesiologists classifica-
tion, BMI body mass index
* Age is given as median
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Long-term outcome
Median survival time was 20 (range, 0–193) months.
Overall 5-year survival was 27.9%, whereas disease-spe-
cific 5-year survival was 33.4%. Disease recurrence was
noted in 315 patients (56.7%): locoregional recurrence in
27.2% and distant metastases in 47.1% of patients. There
was no significant difference in overall 5-year survival
between the different BMI classes (Fig. 1: underweight
26.8%, normal weight 25.2%, overweight 28.5%, and
obesity 34.4%; p = 0.25) or disease-free 5-year survival
(28.8, 32.5, 33.2, and 35.1%, respectively; p = 0.6).
Parameters found to be associated with overall survival in
univariate analyses are shown in Table 4. Age younger
than 65 years, early pT stage (pT1 or pT2), no lymph node
involvement (pN0), absence of distant metastatic disease
(pM0), lymph node ratio smaller than 0.17, good differ-
entiation grade of the tumor, and R0 resection were
favorable for improved survival.
Discussion
In this large cohort of patients who underwent esopha-
gectomy for cancer, no differences in overall morbidity,
in-hospital mortality, or reoperation rate were detected
among the different BMI classes. However, severe com-
plications seemed to occur more often in obese patients
than in the control group. Furthermore, a linear association
between BMI and anastomotic leakage was detected: the
risk for anastomotic leakage increased with higher BMI.
Cancer cachexia has been recognized as a condition
associated with an increased risk of postoperative compli-
cations [2], in particular infectious complications [3].
However, in the present series it appeared that underweight
did not influence the patient’s short-term outcome after
esophagectomy. When analyzing infectious complications
in particular (esp. wound infection and pneumonia), inci-
dences in underweight patients were similar to those in the
control group.
Obese patients are thought to have a higher risk for
developing wound infections [6, 12, 16, 17]. This might be
related to the presence of excessive fatty tissue (with a low
regional oxygen tension), which may predispose to
impaired wound healing. Furthermore, it has been shown
that obese patients have an underlying immune impair-
ment, which may further contribute to higher rates of
wound infection [18]. Although other reports could not
confirm this hypothesis [11, 19, 20], the risk for wound
infection seemed to increase with higher BMI on trend
analysis in the present series. Furthermore, we found a
linear association between BMI and anastomotic leakage: a
higher incidence of anastomotic leakage was found with
increasing BMI. In one study in which a significantly
increased incidence of anastomotic leakage in obese
patients was demonstrated, it was speculated that this might
be due to a compromised vascularity of the conduit
(because of an increased tension on the conduit in the
thoracic compartment or because of medical comorbidities
in general, such as diabetes or cardiovascular disease).
In contrast to previous studies, we did not find differ-
ences in respiratory complications nor in laryngeal nerve
No. at risk 0 months 12 months 24 months 36 months 48 months 60 months 
Underweight 40 26 15 11 11 9 
Normal weight 244 147 97 75 56 46 
Overweight 214 138 89 59 47 40 
Obesity 58 47 33 23 14 10 
Fig. 1 Overall 5-year survival
in relation to BMI classes in 556
patients who underwent surgical
resection for esophageal cancer
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injury between the BMI classes [11, 20]. This discrepancy
with the literature might be explained by a difference in the
applied surgical technique. Whereas the majority of our
patients underwent a transhiatal esophagectomy, in the
previously reported patient group a transthoracic technique
was applied [11]. It is known that transthoracic esopha-
gectomy is associated with more pulmonary complications
compared with the transhiatal approach [21].
In this study advanced pT stage was seen significantly
more often in patients with a low or normal BMI compared
with patients with a high BMI (p = 0.02). This might be
explained by the fact that overweight people experience
more reflux symptoms and are offered upper gastrointes-
tinal endoscopy more frequently, thereby facilitating an
early detection of the esophageal tumor. Furthermore, in
the underweight group patients with a squamous cell car-
cinoma were overrepresented, who would not have entered
a Barrett’s esophagus surveillance program. Indeed,
patients with overweight or obesity were participating
more often in a surveillance program than patients with a
low or normal BMI (28.8 vs. 17.1%), although this dif-
ference did not reach statistical significance (p = 0.21). It
is well-established that stage of disease and survival are
more favorable for patients who have undergone endo-
scopic surveillance than for patients who have not partic-
ipated in a surveillance program [22, 23].
We hypothesized that a higher percentage of tumor-free
circumferential resection margins might be achieved when
performing esophagectomy for cancer in overweight or
obese patients because of the presence of more substantial
fatty tissue surrounding the tumor. Indeed, on trend anal-
ysis, a significant linear association between BMI and
R0-resection rate was found (p = 0.02): 60% in under-
weight patients versus 81% in obese patients. However, pT
stage acted as a confounder for this relationship, because
BMI was not an independent predictor for R0 resection on
logistic regression. Therefore, our hypothesis that a higher
percentage of tumor-free circumferential resection margins
might be achieved in obese patients because of the pres-
ence of more fatty tissue surrounding the tumor could not
be confirmed. Furthermore, higher BMI did not result in
improved long-term survival after resection and BMI class
was not a predictor of survival after esophagectomy in
univariate analysis.
Selection bias may be a limitation of this study, because
only patients who were considered fit enough for an
operation were entered into this study. Therefore, severely
malnourished patients or patients with severe obesity-
associated medical comorbidities (including diabetes,
hypertension, and coronary artery disease) were more
likely to have been excluded from surgery. This may have
lead to a properly selected patient group, sufficiently fit to
undergo esophagectomy, in whom no impact of under-
weight or obesity on patient’s short-term and long-term
outcome could be demonstrated.
In summary, BMI is not of prognostic value with regard
to short-term complications or long-term survival in
patients who undergo esophagectomy for cancer. A radical
R0 resection was achieved more often in patients with high
BMI. However, this was not due to the presence of more
substantial fatty tissue surrounding the tumor (potentially
Table 4 Univariate analyses of variables associated with overall
survival in esophageal cancer patients who underwent surgical
resection
Variable 5-year survival (%) p value
BMI class
Underweight 26.8 0.25
Normal weight 25.2
Overweight 28.5
Obesity 34.4
Gender
Male 26.6 0.5
Female 33.4
Age (year)
\65 33.7 \0.001
C65 22.3
ASA classification
I/II 28.5 0.11
III/IV 25.9
Histology
Squamous cell carcinoma 26.0 0.53
Adenocarcinoma 28.3
pT stage
pT1-2 55.5 \0.001
pT3-4 14.5
pN stage
pN0 52.7 \0.001
pN1 12.9
pM stage
pM0 32.3 \0.001
pM1a/M1b 8.1
Lymph node ratio
\0.17 44.9 \0.001
C0.17 11.5
Differentiation grade of tumor
Good 70.2 \0.001
Moderate 30.3
Poor 19.1
Radicality of resection
R0 37.9 \0.001
R1/R2 4.8
BMI body mass index, ASA classification American society of anes-
thesiologists classification
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facilitating a radical resection). Rather, this observation
should be explained by a confounding effect of pT stage,
because early pT stage was seen more often in patients with
high BMI. We conclude that patients who are oncologically
eligible for esophagectomy should not be denied surgery
on the basis of their BMI class only.
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